다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Aligos Therapeutics Inc (ALGS)
Aligos Therapeutics Inc (ALGS) 뉴스

ALGS

Aligos Therapeutics (ALGS)

Aligos Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALGS

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	05:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/05/08	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/05/08	05:05	GlobeNewswire Inc.	Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/05/01	05:05	GlobeNewswire Inc.	Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/04/26	05:05	GlobeNewswire Inc.	Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/04/25	21:00	GlobeNewswire Inc.	Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/04/09	21:00	GlobeNewswire Inc.	Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/04/03	21:00	GlobeNewswire Inc.	Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/03/27	21:00	GlobeNewswire Inc.	Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/03/18	21:00	GlobeNewswire Inc.	Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/03/13	05:05	GlobeNewswire Inc.	Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/03/06	06:05	GlobeNewswire Inc.	Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/03/05	07:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/03/05	07:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/02/29	07:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/02/29	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/02/29	07:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/02/26	22:00	GlobeNewswire Inc.	Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/02/20	22:00	GlobeNewswire Inc.	Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/02/13	22:00	GlobeNewswire Inc.	Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/01/30	21:04	Edgar (US Regulatory)	Form SC TO-I - Tender offer statement by Issuer	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/01/25	20:12	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:ALGS	Aligos Therapeutics Inc
2024/01/25	20:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/29	06:01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/23	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/18	06:38	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/16	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/08	02:03	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/03	05:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALGS	Aligos Therapeutics Inc
2023/11/03	05:08	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ALGS	Aligos Therapeutics Inc

검색 관련기사 보기:NASDAQ:ALGS

1 2 3 4 5 다음 >>

Gold vs US Dollar

Verizon Communications

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관